Greylin Investment Mangement Has Decreased Micron Technology (MU) Position; Macrogenics (MGNX) Shorts Raised By 19.38%

November 15, 2017 - By Kurt Siggers

Macrogenics Incorporated (NASDAQ:MGNX) had an increase of 19.38% in short interest. MGNX’s SI was 4.13 million shares in November as released by FINRA. Its up 19.38% from 3.46 million shares previously. With 560,300 avg volume, 7 days are for Macrogenics Incorporated (NASDAQ:MGNX)’s short sellers to cover MGNX’s short positions. The SI to Macrogenics Incorporated’s float is 13.06%. About shares traded. MacroGenics Inc (NASDAQ:MGNX) has declined 9.76% since November 15, 2016 and is downtrending. It has underperformed by 26.46% the S&P500.

Greylin Investment Mangement Inc decreased Micron Technology Inc (MU) stake by 61.04% reported in 2017Q2 SEC filing. Greylin Investment Mangement Inc sold 27,500 shares as Micron Technology Inc (MU)’s stock rose 19.14%. The Greylin Investment Mangement Inc holds 17,555 shares with $524,000 value, down from 45,055 last quarter. Micron Technology Inc now has $51.74B valuation. The stock declined 2.05% or $0.94 reaching $44.86 per share. About 223,115 shares traded. Micron Technology, Inc. (NASDAQ:MU) has risen 176.27% since November 15, 2016 and is uptrending. It has outperformed by 159.57% the S&P500.

Analysts await Micron Technology, Inc. (NASDAQ:MU) to report earnings on December, 20. They expect $2.12 EPS, up 657.14% or $1.84 from last year’s $0.28 per share. MU’s profit will be $2.45 billion for 5.29 P/E if the $2.12 EPS becomes a reality. After $1.99 actual EPS reported by Micron Technology, Inc. for the previous quarter, Wall Street now forecasts 6.53% EPS growth.

Investors sentiment increased to 1.08 in 2017 Q2. Its up 0.03, from 1.05 in 2017Q1. It improved, as 63 investors sold MU shares while 217 reduced holdings. 85 funds opened positions while 218 raised stakes. 832.79 million shares or 1.90% less from 848.93 million shares in 2017Q1 were reported. Thrivent For Lutherans, Minnesota-based fund reported 41,791 shares. Louisiana State Employees Retirement Systems has 0.09% invested in Micron Technology, Inc. (NASDAQ:MU). Scout Inc invested in 562,377 shares or 0.49% of the stock. Platinum Invest Management Limited owns 24,000 shares for 0.02% of their portfolio. 186,086 are held by Elm Ridge Lc. Asset owns 102,394 shares. Mitsubishi Ufj Trust & Corp invested 0.13% in Micron Technology, Inc. (NASDAQ:MU). Hilltop Inc stated it has 0.16% of its portfolio in Micron Technology, Inc. (NASDAQ:MU). Employees Retirement Association Of Colorado holds 0.04% or 199,453 shares in its portfolio. Rhumbline Advisers holds 0.12% or 1.76 million shares. Fic Cap reported 10,000 shares. California State Teachers Retirement invested in 0.12% or 1.94 million shares. 19.67M were reported by Ameriprise Fincl Incorporated. Hsbc Public Limited Co reported 1.23M shares or 0.07% of all its holdings. Texas Permanent School Fund has 292,189 shares.

Since May 16, 2017, it had 0 insider buys, and 3 sales for $650,750 activity. $300,000 worth of Micron Technology, Inc. (NASDAQ:MU) was sold by Deboer Scott J on Tuesday, May 30. The insider Byrne Patrick J sold $408,911. ARNZEN APRIL S sold 1,000 shares worth $30,750.

Among 42 analysts covering Micron Technology Inc. (NASDAQ:MU), 35 have Buy rating, 1 Sell and 6 Hold. Therefore 83% are positive. Micron Technology Inc. had 187 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Citigroup given on Tuesday, July 11. Wells Fargo maintained the shares of MU in report on Wednesday, September 27 with “Outperform” rating. The firm has “Overweight” rating given on Thursday, December 17 by Morgan Stanley. Cowen & Co maintained Micron Technology, Inc. (NASDAQ:MU) on Thursday, December 22 with “Outperform” rating. The firm earned “Reduce” rating on Monday, March 7 by Nomura. The firm has “Buy” rating by Stifel Nicolaus given on Friday, July 1. Robert W. Baird upgraded Micron Technology, Inc. (NASDAQ:MU) on Tuesday, May 31 to “Outperform” rating. The rating was maintained by Stifel Nicolaus on Monday, June 26 with “Buy”. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, September 29. Argus Research maintained the shares of MU in report on Thursday, December 24 with “Buy” rating.

Among 10 analysts covering MacroGenics (NASDAQ:MGNX), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. MacroGenics had 19 analyst reports since August 6, 2015 according to SRatingsIntel. As per Friday, November 10, the company rating was maintained by Citigroup. Citigroup downgraded the shares of MGNX in report on Thursday, August 4 to “Neutral” rating. The rating was downgraded by Zacks on Monday, August 10 to “Buy”. On Thursday, February 18 the stock rating was initiated by Janney Capital with “Buy”. The firm has “Equal-Weight” rating given on Monday, August 7 by Morgan Stanley. Citigroup upgraded the stock to “Buy” rating in Monday, October 19 report. SunTrust maintained the shares of MGNX in report on Friday, September 1 with “Buy” rating. Morgan Stanley initiated the shares of MGNX in report on Thursday, February 25 with “Equal-Weight” rating. SunTrust initiated MacroGenics Inc (NASDAQ:MGNX) rating on Tuesday, December 20. SunTrust has “Buy” rating and $30 target. The firm earned “Buy” rating on Thursday, August 6 by Stifel Nicolaus.

Investors sentiment increased to 1.73 in Q2 2017. Its up 0.87, from 0.86 in 2017Q1. It is positive, as 11 investors sold MacroGenics Inc shares while 22 reduced holdings. 15 funds opened positions while 42 raised stakes. 27.45 million shares or 1.31% more from 27.10 million shares in 2017Q1 were reported. State Board Of Administration Of Florida Retirement Systems, Florida-based fund reported 16,091 shares. Parametric Port Associates Ltd Liability Co reported 11,578 shares. Northwestern Mutual Wealth Management Company owns 27 shares for 0% of their portfolio. Bnp Paribas Arbitrage has invested 0% in MacroGenics Inc (NASDAQ:MGNX). Jacobs Levy Equity Management Inc has 0.01% invested in MacroGenics Inc (NASDAQ:MGNX) for 19,390 shares. Citigroup, a New York-based fund reported 18,975 shares. Next Fincl has invested 0% of its portfolio in MacroGenics Inc (NASDAQ:MGNX). Meeder Asset invested 0% in MacroGenics Inc (NASDAQ:MGNX). American Intl Gru Incorporated holds 0% of its portfolio in MacroGenics Inc (NASDAQ:MGNX) for 20,637 shares. Hood River Capital Mgmt Ltd Company has 576,193 shares. Wasatch Advsrs holds 1.04M shares. Alliancebernstein L P reported 43,000 shares stake. Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in MacroGenics Inc (NASDAQ:MGNX) for 1,465 shares. Los Angeles Cap Mgmt & Equity Rech owns 26,160 shares or 0% of their US portfolio. Vident Investment Advisory has invested 0.09% in MacroGenics Inc (NASDAQ:MGNX).

Since June 5, 2017, it had 0 buys, and 1 insider sale for $100,000 activity. The insider Wigginton Jon Marc sold $100,000.

MacroGenics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing monoclonal antibody therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The company has market cap of $656.18 million. The Firm develops therapeutic product candidates using its antibody technology platforms and also in collaboration with other biopharmaceutical companies. It currently has negative earnings. It has a pipeline of product candidates in human clinical testing, primarily as treatments for different types of cancers, which are created using its technology platforms.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Kurt Siggers




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: